Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Venkata Vamsi Krishna Venuganti"'
Publikováno v:
ACS Omega, Vol 9, Iss 40, Pp 41565-41582 (2024)
Externí odkaz:
https://doaj.org/article/480438874f5840cc9e1a5ddb8d9cf1d3
Publikováno v:
ACS Omega, Vol 5, Iss 31, Pp 19905-19918 (2020)
Externí odkaz:
https://doaj.org/article/746a20332c644e568e70852897a38c5f
Autor:
Shubhmita Bhatnagar, Sumeet Rajesh Chawla, Onkar Prakash Kulkarni, Venkata Vamsi Krishna Venuganti
Publikováno v:
ACS Omega, Vol 2, Iss 4, Pp 1321-1332 (2017)
Externí odkaz:
https://doaj.org/article/a7ef0c2db8f949aca3266ae02089fedd
Publikováno v:
Langmuir. 39:5591-5601
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::291d941ce1a53be1891711a8f0f215b9
https://doi.org/10.1021/acs.langmuir.3c00525
https://doi.org/10.1021/acs.langmuir.3c00525
Publikováno v:
Journal of Chemical Sciences. 135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49216d75259e8ddc7299763f50e92ba0
https://doi.org/10.1007/s12039-023-02149-2
https://doi.org/10.1007/s12039-023-02149-2
Publikováno v:
International journal of pharmaceutics. 631
The development of a long-acting orally administered dosage form is a challenge. Here, we report development of a multi-layered mucoadhesive gastric patch that could deliver entrapped chemotherapeutic agent for eight days after oral administration. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f55882b19c09fe8dee1403bdb47ce72
https://pubmed.ncbi.nlm.nih.gov/36529359
https://pubmed.ncbi.nlm.nih.gov/36529359
Autor:
Raghuraman Manimaran, Kinnari Dinesh Patel, Venessa Maurice Lobo, Shubham Suresh Kumbhar, Venkata Vamsi Krishna Venuganti
Publikováno v:
International Journal of Pharmaceutics. 640:122991
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db79e3542005b6f1ca8df1001174f891
https://doi.org/10.1016/j.ijpharm.2023.122991
https://doi.org/10.1016/j.ijpharm.2023.122991
Autor:
Leela Sai Lokesh Janardhanam, Ashwini Suresh Deokar, Srivarsha Reddy Bollareddy, Venkata Vamsi Krishna Venuganti
The aim of the study was to investigate the pharmacokinetic parameters of 5-fluorouracil (5FU) and moxifloxacin (MF) after oral administration using layer-by-layer assembled film in enteric coated capsule. The LbL film was prepared by sequential laye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b52962605e3e4ed925aef23b83e36ab
https://doi.org/10.21203/rs.3.rs-1750266/v1
https://doi.org/10.21203/rs.3.rs-1750266/v1
Publikováno v:
ACS applied materialsinterfaces. 14(8)
The aim of the study was to develop and evaluate the efficacy of a functionalized layer-by-layer (LbL) assembled film entrapped with oxaliplatin (OX) and signal transducer and activator of transcription 3 (STAT3) siRNA in the localized treatment of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74bf8744dd33af9ce8db92c67b34c52a
https://pubmed.ncbi.nlm.nih.gov/35170934
https://pubmed.ncbi.nlm.nih.gov/35170934
Autor:
Srivarsha Reddy Bollareddy, Vandana Krishna, Girdhari Roy, Deepika Dasari, Arti Dhar, Venkata Vamsi Krishna Venuganti
Publikováno v:
AAPS PharmSciTech. 23
Oral cancer is one of the most common malignancies with an increased rate of incidence. 5-Fluorouracil (5FU) is an effective chemotherapeutic indicated for oral cancer treatment. Etodolac (Et), a cyclooxygenase-2 inhibitor, can be used as an adjuvant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79bbc187837a4f409f1bf76655511fca
https://doi.org/10.1208/s12249-022-02221-z
https://doi.org/10.1208/s12249-022-02221-z